Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Atara and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click […]

Pomerantz LLP is investigating claims on behalf of investors of Edison International (“Edison” or the “Company”) (NYSE:EIX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Edison and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. (“Keros” or the “Company”) (NASDAQ: KROS).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Keros and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

97.8% of Q4 2024 survey respondents are aware of flexible work arrangement policies, while most expect merit-based salary increases and bonuses Reeracoen, Asia's leading human resource services provider, is unveiling its latest report: Unlocking Success in 2025: Navigating Pay Structures & Flexible Work Arrangements. Based on an extensive fourth quarter 2024 survey, the report offers

(NASDAQ:PCRX), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”). A lawsuit

(TSX:WDO),(OTC US:WDOFF),(Other OTC:WDOFF), TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX:WDO, OTCQX:WDOFF) (“Wesdome” or the “Company“) today provides a comprehensive update on its exploration activities (Figure 1) at its wholly-owned Eagle River Mine (“Eagle River“) near Wawa, Ontario. Anthea Bath, President and Chief Executive Officer, stated, “Eagle River delivered exceptional exploration

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marqeta, Inc. (NASDAQ:MQ) between May 7, 2024 and November 4, 2024, both dates inclusive (the "Class Period"), of the important February 7, 2025 lead plaintiff deadline in the securities

Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. (“4D” or the “Company”)(NASDAQ: FDMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether 4D and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

BARCELONA, ES / ACCESS Newswire / January 21, 2025 / As scientists say, spending money on experiences leads to more satisfaction and well-being than material goods, and cruises represent exactly that, providing adventure, leisure, and global discovery. It’s a one-of-a-kind experience, but like any journey, planning is essential. In this guide, we’ll help first-time cruisers

Pomerantz LLP announces that a class action lawsuit has been filed against MGP Ingredients, Inc. (“MGPI” or the “Company”)(NASDAQ: MGPI).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.